Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Carbiotix (publ) ("Carbiotix" or "Company") announces today that the Company sees a growing interest in its LinkGut service from around the world. Since its launch as a B2B white label microbiome testing service in 2021, LinkGut has developed and matured as a result of partner feedback. Key partners in this development phase include Injoy from Canada, Myota from Switzerland and Symbiome from Sweden.
Kristofer Cook, CEO of Carbiotix, comments
"I am very happy to see a growing interest in the LinkGut service. Our ambition when we launched the service in 2021 was to offer the most cost efficient, flexible and reliable B2B white label consumer microbiome testing service in the world. I am happy to say that we achieved this goal and continually see opportunities to further improve the service. An important part of this improvement process has been feedback from our early partners. Three of these partners are Injoy, Myota and Symbiome. Injoy (www.injoy.bio) is a service offered by Phyla in Canada focused on gut health released diseases and Artificial Intelligence (AI). Myota (www.myotahealth.com) is a company based in Switzerland focused on patented prebiotic fiber blends. Symbiome (www.symbiome.se) is a Swedish based company focused on gut microbiome health and lifestyle recommendations.
Injoy, Myota and Symbiome represent a very good cross section of the types of services and companies that continually contact Carbiotix and inquire about our LinkGut service, either company focused on gut related diseases, consumer products or health advisory services. Whether operating as a start-up or as an established company, all companies seeking a microbiome testing service prioritize affordability, reliability and flexibility. We have used our interaction with each company to accomplish this and find ways to push down costs further, increase reliability and improve the flexibility of the LinkGut service. I am very happy to say that this partner driven innovation has resulted in stronger relationships with our partners, a growing reputation in the market as a leading service provider, and a more appealing service offering overall. I certainly welcome the growing interest in the LinkGut service and look forward to further expanding our partner network in the months and years to come and making the LinkGut service even more compelling with our partners."
Forward-looking statements
This communication contains forward-looking statements, consisting of subjective assumptions and forecasts for future scenarios. Predictions for the future only apply as of the date they are made and are, by their nature, as is research and development work in the biotechnology segment, associated with risk and uncertainty. With this in mind, the actual outcome may deviate significantly from the scenarios as described in this press release.